Developmental and therapeutic implications of molecular profiles of ER-positive and ER-negative breast cancers.

被引：0

作者：

Perou, CM ^{[1
]}

机构：

[1] Univ N Carolina, Chapel Hill, NC USA

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S3 / S3

页数：1

共 50 条

[31] Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial [J].

Wapnir, Irene L. ;

Price, Karen N. ;

Anderson, Stewart J. ;

Robidoux, Andre ;

Martin, Miguel ;

Nortier, Johan W. R. ;

Paterson, Alexander H. G. ;

Rimawi, Mothaffar F. ;

Lang, Istvan ;

Manuel Baena-Canada, Jose ;

Thurlimann, Beat ;

Mamounas, Eleftherios P. ;

Geyer, Charles E., Jr. ;

Gelber, Shari ;

Coates, Alan S. ;

Gelber, Richard D. ;

Rastogi, Priya ;

Regan, Meredith M. ;

Wolmark, Norman ;

Aebi, Stefan .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (11) :1073-+

[32] Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system [J].

Xiao, Bin ;

Hang, Jianfeng ;

Lei, Ting ;

He, Yongyin ;

Kuang, Zhenzhan ;

Wang, Li ;

Chen, Lidan ;

He, Jia ;

Zhang, Weiyun ;

Liao, Yang ;

Sun, Zhaohui ;

Li, Linhai .

MOLECULAR BIOLOGY REPORTS, 2019, 46 (02) :2111-2119

[33] Radiation Therapy Use and Outcomes Among Older Women With ER-Positive and ER-Negative Stage I Breast Cancer [J].

Shen, Xinglei ;

Anne, Pramila R. ;

Keith, Scott W. ;

Wojcieszynski, Andrzej ;

Mishra, Mark V. ;

Bar-Ad, Voichita ;

Showalter, Timothy N. .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (03) :241-247

[34] Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer [J].

Witton, CJ ;

Hawe, SJK ;

Cooke, TG ;

Bartlett, JMS .

HISTOPATHOLOGY, 2004, 45 (01) :47-54

[35] Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system [J].

Bin Xiao ;

Jianfeng Hang ;

Ting Lei ;

Yongyin He ;

Zhenzhan Kuang ;

Li Wang ;

Lidan Chen ;

Jia He ;

Weiyun Zhang ;

Yang Liao ;

Zhaohui Sun ;

Linhai Li .

Molecular Biology Reports, 2019, 46 :2111-2119

[36] ANALYSIS OF THE ESTROGEN-RECEPTOR (ER) GENE, TRANSCRIPT AND PROTEIN IN ER-POSITIVE AND ER-NEGATIVE BREAST-CANCER CELL-LINES [J].

YAICH, LE ;

ROODI, N ;

BAILEY, LR ;

VERRIER, CS ;

YEE, CJ ;

CAVENER, DR ;

PARL, FF .

[37] High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers [J].

Cecilia Ahlin ;

Claudia Lundgren ;

Elin Embretsén-Varro ;

Karin Jirström ;

Carl Blomqvist ;

M. -L. Fjällskog .

Breast Cancer Research and Treatment, 2017, 164 :667-678

[38] High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers [J].

Ahlin, Cecilia ;

Lundgren, Claudia ;

Embretsen-Varro, Elin ;

Jirstrom, Karin ;

Blomqvist, Carl ;

Fjallskog, M. -L. .

BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (03) :667-678

[39] Rapid Activation of cPLA2α Induced by Estrogen in ER-Positive and ER-Negative Breast Cancer Cell Lines. [J].

Caiazza, F. ;

Thomas, W. ;

Harvey, B. J. .

ENDOCRINE REVIEWS, 2010, 31 (03)

[40] INFLUENCE OF HORMONES ON PROLIFERATION OF ER-POSITIVE CELLS AND ER-NEGATIVE CELLS OF HUMAN-BREAST CANCER (MCF-7) [J].

NOGUCHI, M ;

TAJIRI, K ;

TANIYA, T ;

KUMAKI, T ;

ASHIKARI, A ;

MIYAZAKI, I .

ONCOLOGY, 1990, 47 (01) :19-24

← 1 2 3 4 5 →